|
22
|
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
RFA-CA-28-013 · National Institutes of Health · evaluation research
|
biomedical clinical
public health
environment
|
$700,000 |
2026-10-09 |
2027-02-09 |
96 |
|
20
|
Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)
PAR-25-449 · National Institutes of Health · evaluation research
|
public health
biomedical clinical
mental behavioral health
|
— |
2025-09-26 |
2028-06-07 |
580 |
|
18
|
Notice of Intent: Program to End Modern Slavery FY 2025
DFOP0017042 · Office to Monitor-Combat Trafficking in Persons · evaluation research
|
justice law
social services
international affairs
|
— |
2025-01-16 |
2099-01-01 |
26355 |
|
16
|
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
PAR-25-207 · National Institutes of Health · evaluation research
|
mental behavioral health
biomedical clinical
social services
|
— |
2024-10-31 |
2028-01-07 |
428 |
|
15
|
Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)
PAR-28-091 · National Institutes of Health · evaluation research
|
biomedical clinical
mental behavioral health
public health
|
$500,000 |
2026-10-15 |
2029-11-16 |
1107 |
|
12
|
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
PAR-25-179 · National Institutes of Health · evaluation research
|
mental behavioral health
biomedical clinical
public health
|
— |
2024-11-26 |
2027-10-15 |
344 |
|
8
|
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
PAR-25-026 · National Institutes of Health · evaluation research
|
biomedical clinical
public health
|
— |
2024-12-05 |
2027-02-03 |
90 |
|
8
|
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
PAR-25-180 · National Institutes of Health · evaluation research
|
biomedical clinical
mental behavioral health
public health
|
— |
2024-11-26 |
2027-10-15 |
344 |
|
8
|
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
PAR-25-343 · National Institutes of Health · evaluation research
|
biomedical clinical
public health
mental behavioral health
|
— |
2025-01-06 |
2027-10-18 |
347 |
|
8
|
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
PAR-25-206 · National Institutes of Health · evaluation research
|
mental behavioral health
biomedical clinical
public health
|
— |
2024-10-31 |
2028-01-07 |
428 |
|
3
|
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
PAR-25-025 · National Institutes of Health · evaluation research
|
biomedical clinical
public health
ai data science
|
$1,515,000 |
2024-12-05 |
2027-02-03 |
90 |
|
3
|
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
PAR-25-183 · National Institutes of Health · evaluation research
|
mental behavioral health
biomedical clinical
|
— |
2024-11-26 |
2027-10-15 |
344 |